Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Meridian Bioscience Company Profile (NASDAQ:VIVO)

Consensus Ratings for Meridian Bioscience (NASDAQ:VIVO) (?)
Ratings Breakdown: 1 Sell Rating(s), 2 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $21.33 (17.22% upside)

Analysts' Ratings History for Meridian Bioscience (NASDAQ:VIVO)
Show:
DateFirmActionRatingPrice TargetActions
5/4/2015Canaccord GenuityBoost Price TargetHold$19.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/26/2015Canaccord GenuityReiterated RatingHold$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/26/2015Canaccord GenuitySet Price TargetHold$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/23/2015Craig HallumUpgradeHold -> Buy$19.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/2/2015Raymond JamesDowngradeMarket Perform -> UnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2014Robert W. BairdDowngradeOutperform -> Neutral$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/25/2014Cowen and CompanyLower Price Target$24.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/26/2013Canaccord GenuityBoost Price TargetHold$20.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/26/2013WedbushUpgradeUnderperform -> Neutral$17.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/16/2013Cowen and CompanyDowngradeOutperform -> Market Perform$23.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/30/2013 forward)